Anuh Pharma Ltd
NSE: ANUHPHR BSE: 506260
₹78.25
(2.65%)
Wed, 18 Mar 2026, 06:32 am
Market Cap7.69B
PE Ratio18.75
Dividend1.95
Company History
1961
- Anuh Pharma Ltd was incorporated.
2006
- The promoters sold off nearly 14.9% of their stake in the company.
- Anuh Pharma has given the Bonus in the Ratio of 1:1
- Company has split its Face value of Shares from Rs 10 to Rs 5
2010
- Anuh Pharma has given the Bonus in the Ratio of 2:1
2011
- Anuh Pharma has recommended a Dividend of Rs. 5.00 per share of face value of Rs. 5.00.
2012
- Anuh Pharma Ltd has entered into a Memorandum of Understanding with M/s. Invent Pharma Pvt. Ltd., to acquire all fixed assets of their Research & Development Laboratory.
- Anuh Pharma has recommended a dividend of Rs. 5.50 per equity share of face value of Rs. 5.00.
2013
- Anuh Pharma has recommended a dividend of Rs. 6.00 per equity share of face value of Rs. 5.00.
2014
- Anuh Pharma Ltd have received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of Companys Erythromycin products
- Anuh Pharma has recommended a Final Dividend of Rs. 6.50 (130%) per share.
2015
- The Company has allotted the Bonus Shares to its shareholders in the Ratio of 2:1.
2016
- Anu Pharma Ltd has received EUGMP Certificate granted by ANSM - France.
2020
- The Company has issued Bonus Shares in the Ratio of 1:1.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800